Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results
![Alphyn Logo 1 Alphyn Logo 1](https://v769c6.p3cdn1.secureserver.net/wp-content/uploads/2021/04/Alphyn-Logo-1-200x200.png)
![Alphyn MOPD 2024 Poster Interim Results Final](https://v769c6.p3cdn1.secureserver.net/wp-content/uploads/2024/02/Alphyn-MOPD-2024-Poster-Interim-Results-Final.jpg?time=1721753391)
CONTACTS
Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687
Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195